4-(2-Chloropropanoyl)-3,3-dimethyl-1,2,3,4-tetrahydroquinoxalin-2-one

Catalog No.: 
ACMOFH872
CAS No.: 
879319-10-5
Molecular Formula: 
C13H15ClN2O2
Molecular Weight: 
266.73
4-(2-Chloropropanoyl)-3,3-dimethyl-1,2,3,4-tetrahydroquinoxalin-2-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$178.00InquiryInquiry
5g95%$506.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(2-Chloropropanoyl)-3,3-dimethyl-1,2,3,4-tetrahydroquinoxalin-2-one
IUPAC Name4-(2-chloropropanoyl)-3,3-dimethyl-3,4-dihydroquinoxalin-2(1H)-one
MDL No.MFCD08261043
Molecular FormulaC13H15ClN2O2
Molecular Weight266.73
SMILESO=C1NC2=C(C=CC=C2)N(C(C(Cl)C)=O)C1(C)C
InChI KeyKZQJRLJQZBOKNH-UHFFFAOYSA-N
Synonym4-(2-chloropropanoyl)-3,3-dimethyl-1,2,3,4-tetrahydroquinoxalin-2-one;2(1H)-Quinoxalinone, 4-(2-chloro-1-oxopropyl)-3,4-dihydro-3,3-dimethyl-
CAS No.879319-10-5

Synthetic Route by SureRoute

1. ACMOFH872 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUPXC209 route compound structure diagram
    ACUPXC20980636-30-2In Stock
  4. Then
  5. ACMOFH872 route product structure diagram
    ACMOFH872879319-10-5
Inquiry

2. ACMOFH872 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUPXC209 route compound structure diagram
    ACUPXC20980636-30-2In Stock
  4. Then
  5. ACMOFH872 route product structure diagram
    ACMOFH872879319-10-5
Inquiry

3. ACMOFH872 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUPXC209 route compound structure diagram
    ACUPXC20980636-30-2In Stock
  4. Then
  5. ACMOFH872 route product structure diagram
    ACMOFH872879319-10-5
Inquiry

Comments (0)